Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Healthequity (HQY) EBIAT (2016 - 2026)

Healthequity (HQY) has 13 years of EBIAT data on record, last reported at $51.7 million in Q4 2025.

  • For Q4 2025, EBIAT rose 806.4% year-over-year to $51.7 million; the TTM value through Oct 2025 reached $191.8 million, up 98.36%, while the annual FY2025 figure was $96.7 million, 73.58% up from the prior year.
  • EBIAT reached $51.7 million in Q4 2025 per HQY's latest filing, down from $59.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $59.8 million in Q3 2025 and bottomed at -$32.8 million in Q1 2022.
  • Average EBIAT over 5 years is $12.6 million, with a median of $5.5 million recorded in 2021.
  • Peak YoY movement for EBIAT: plummeted 2479.73% in 2021, then soared 12714.35% in 2024.
  • A 5-year view of EBIAT shows it stood at -$5.0 million in 2021, then surged by 67.43% to -$1.6 million in 2022, then surged by 994.15% to $14.7 million in 2023, then plummeted by 61.13% to $5.7 million in 2024, then soared by 806.4% to $51.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $51.7 million in Q4 2025, $59.8 million in Q3 2025, and $53.9 million in Q2 2025.